DuChemBIO Co.,Ltd. (KOSDAQ:176750)

DuChemBIO Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
Net Income	7,994	4,001
Depreciation & Amortization	5,565	5,760
Loss (Gain) From Sale of Assets	0.18	-16.28
Asset Writedown & Restructuring Costs	-	30.7
Loss (Gain) From Sale of Investments	-387.82	-92.13
Loss (Gain) on Equity Investments	-1,106	69.64
Stock-Based Compensation	31.97	236.54
Provision & Write-off of Bad Debts	156.15	-165.84
Other Operating Activities	-2,039	929.66
Change in Accounts Receivable	-1,834	-131.89
Change in Inventory	-74.64	-534.11
Change in Accounts Payable	-597.38	411.37
Change in Other Net Operating Assets	-679.24	-2,057
Operating Cash Flow	7,029	8,441
Operating Cash Flow Growth	-16.73%	-
Capital Expenditures	-1,589	-1,147
Sale of Property, Plant & Equipment	-	31
Sale (Purchase) of Intangibles	-283.1	-150
Investment in Securities	11.06	-
Other Investing Activities	-204.41	-132.8
Investing Cash Flow	-1,816	-1,299
Long-Term Debt Repaid	-7,925	-7,766
Net Debt Issued (Repaid)	-7,925	-7,766
Issuance of Common Stock	11,440	-
Other Financing Activities	-7.75	-
Financing Cash Flow	3,507	-7,766
Foreign Exchange Rate Adjustments	-	-0.19
Net Cash Flow	8,720	-624.54
Free Cash Flow	5,440	7,293
Free Cash Flow Growth	-25.41%	-
Free Cash Flow Margin	15.28%	21.02%
Free Cash Flow Per Share	202.79	273.46
Cash Interest Paid	1,087	919.41
Cash Income Tax Paid	144.92	90.38
Levered Free Cash Flow	4,629	-
Unlevered Free Cash Flow	5,311	-
Change in Net Working Capital	1,555	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.